A blog about the intersection of medicine and business, produced by the members of the Medical Consumerism seminar at the University of Minnesota.
Saturday, January 21, 2006
Black box warning?
GlaxoSmithKline wants to market an over-the-counter version of its diet pill Xenical. The good news: an FDA reviewer says it is a safe and effective weight loss agent. The bad news: side-effects include "involuntary leakage of undigested fat."
No comments:
Post a Comment